First results from BladderPath: A randomised trial of MRI versus cystoscopic staging for newly diagnosed bladder cancer

NOVEL THERAPIES FOR HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER.

COMPARISON OF ROBOT-ASSISTED AND OPEN RADICAL CYSTECTOMY IN RECOVERY OF PATIENT-REPORTED AND PERFORMANCE-RELATED MEASURES OF INDEPENDENCEA SECONDARY ANALYSIS OF A RANDOMIZED CLINICAL TRIAL

Welcome & Introduction

Decoding Treatment Options for EGFRm NSCLC

Osimertinib as Adjuvant Therapy in patients with resected EGFRm Stage IB IIIA NSCLC-Updated Results from ADAURA

Welcome & Introduction

Cancer Awareness, Screening & Early diagnosis. Where are we now and what are the solutions- India Centric?

Panel Discussion - Access to cancer treatment. Current milestones & way forward for cancer care for all, in India.

Welcome & Introduction

Role of Alecensa in 1L ALK+ NSCLC patients Beyond The Barriers

Lorlatinib as a first line option for ALK positive metastatic NSCLC